The present invention relates to bi- and tricyclic compounds of the general formula (I) (I) wherein the dashed lines independently of each other represent a single or a double bond, X represents a group of the formulae X.sub.1 to X.sub.3 wherein the asterisk denotes the point of attachment to the rest of the molecule, R.sup.1a and R.sup.1b, independently of each other, are selected from hydrogen or methyl, or R.sup.1a together with R.sup.1b with R form a methylene or ethylene group, R.sup.2, R.sup.3a, R.sup.3b, R.sup.4, R.sup.5a and R.sup.5b, independently of each other, are selected from hydrogen or methyl, R.sup.6 is selected from hydrogen, methyl or ethyl, and R.sup.7 is methyl or ethyl, to a method of preparing said compounds, to the use of a bi- or tricyclic compounds or of mixtures of two or more bi- and tricyclic compounds or of a stereoisomer thereof or of a mixture of two or more stereoisomers thereof as aroma chemicals; to the use of a bi- or tricyclic compound for modifying the scent character of a fragranced composition; to an aroma chemical composition containing a bi- or tricyclic compound or a mixture of two or more bi- and tricyclic compounds or of a stereoisomer thereof or of a mixture of two or more stereoisomers thereof; and to a method of preparing a fragranced composition or for modifying the scent character of a fragranced composition, comprising incorporating a bi- or tricyclic compound or a mixture of two or more bi- and tricyclic compounds or of a stereoisomer thereof or of a mixture of two or more stereoisomers thereof into said composition.

##STR00001##

The present invention relates to bi- and tricyclic compounds of the general formula (I) (I) wherein the dashed lines independently of each other represent a single or a double bond, X represents a group of the formulae X.sub.1 to X.sub.3 wherein the asterisk denotes the point of attachment to the rest of the molecule, R.sup.1a and R.sup.1b, independently of each other, are selected from hydrogen or methyl, or R.sup.1a together with R.sup.1b with R form a methylene or ethylene group, R.sup.2, R.sup.3a, R.sup.3b, R.sup.4, R.sup.5a and R.sup.5b, independently of each other, are selected from hydrogen or methyl, R.sup.6 is selected from hydrogen, methyl or ethyl, and R.sup.7 is methyl or ethyl, to a method of preparing said compounds, to the use of a bi- or tricyclic compounds or of mixtures of two or more bi- and tricyclic compounds or of a stereoisomer thereof or of a mixture of two or more stereoisomers thereof as aroma chemicals; to the use of a bi- or tricyclic compound for modifying the scent character of a fragranced composition; to an aroma chemical composition containing a bi- or tricyclic compound or a mixture of two or more bi- and tricyclic compounds or of a stereoisomer thereof or of a mixture of two or more stereoisomers thereof; and to a method of preparing a fragranced composition or for modifying the scent character of a fragranced composition, comprising incorporating a bi- or tricyclic compound or a mixture of two or more bi- and tricyclic compounds or of a stereoisomer thereof or of a mixture of two or more stereoisomers thereof into said composition.

##STR00001##

Trans isomers of formula (I) in the form of any of its stereoisomers or a mixture thereof are provided, wherein the bold and hatched lines indicate a relative or absolute configuration. Also provided are their uses as perfuming ingredients to impart vetiver/rooty notes e.g. in perfuming compositions or in consumer products.

##STR00001##

Trans isomers of formula (I) in the form of any of its stereoisomers or a mixture thereof are provided, wherein the bold and hatched lines indicate a relative or absolute configuration. Also provided are their uses as perfuming ingredients to impart vetiver/rooty notes e.g. in perfuming compositions or in consumer products.

##STR00001##

The invention relates to substituted adamantane compounds, pharmaceutical compositions thereof, processes for their preparation, and methods for inhibiting sphingosine kinase and for treating or preventing hyperproliferative disease, inflammatory disease, or angiogenic disease.

The invention relates to substituted adamantane compounds, pharmaceutical compositions thereof, processes for their preparation, and methods for inhibiting sphingosine kinase and for treating or preventing hyperproliferative disease, inflammatory disease, or angiogenic disease.

A rare earth complex including a rare earth ion and a ligand coordinated with the rare earth ion and having a condensed polycyclic aromatic group. The condensed polycyclic aromatic group is a residue formed by removing a hydrogen atom from a condensed polycyclic aromatic compound represented by the following formula (I) or (II):

##STR00001##

A rare earth complex including a rare earth ion and a ligand coordinated with the rare earth ion and having a condensed polycyclic aromatic group. The condensed polycyclic aromatic group is a residue formed by removing a hydrogen atom from a condensed polycyclic aromatic compound represented by the following formula (I) or (II):

##STR00001##

Provided is an electronic apparatus including: a substrate; a pixel defined layer defining a plurality of pixel areas and a plurality of non-pixel areas on the substrate; a plurality of light-emitting diodes arranged on the plurality of the pixel areas; and a thin film encapsulation portion including an organic film and sealing the pixel defined layer, or the plurality of the light-emitting diodes and the pixel defined layer, wherein the organic film includes a curable material of a composition for forming an organic film, the composition including at least one UV absorber.

Provided is an electronic apparatus including: a substrate; a pixel defined layer defining a plurality of pixel areas and a plurality of non-pixel areas on the substrate; a plurality of light-emitting diodes arranged on the plurality of the pixel areas; and a thin film encapsulation portion including an organic film and sealing the pixel defined layer, or the plurality of the light-emitting diodes and the pixel defined layer, wherein the organic film includes a curable material of a composition for forming an organic film, the composition including at least one UV absorber.